Wound Care (Pharmacies) - Austria

  • Austria
  • Revenue in the Wound Care market is projected to reach US$36.06m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.58%, resulting in a market volume of US$37.11m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$1,042.00m in 2024).
  • In relation to total population figures, per person revenues of US$4.02 are generated in 2024.

Key regions: China, South Korea, Japan, Canada, India

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Wound Care (Pharmacies) market in Austria is experiencing steady growth due to increasing customer preferences for advanced wound care products and the rising prevalence of chronic wounds.

Customer preferences:
Customers in Austria are increasingly opting for advanced wound care products that offer faster healing and better outcomes. This shift in preference can be attributed to the growing awareness about the benefits of advanced wound care solutions, such as hydrogels, foam dressings, and antimicrobial dressings. These products provide a moist wound environment, promote faster healing, and reduce the risk of infection. Additionally, customers are also seeking products that are easy to use and require minimal maintenance, such as self-adhesive dressings and wound closure devices.

Trends in the market:
One of the key trends in the Wound Care (Pharmacies) market in Austria is the increasing adoption of telemedicine and remote patient monitoring. This trend has been accelerated by the COVID-19 pandemic, as it allows healthcare professionals to remotely assess and monitor wound healing progress. Telemedicine enables patients to receive timely advice and guidance from healthcare professionals, reducing the need for in-person visits and improving convenience for patients. This trend is expected to continue as telemedicine becomes more integrated into the healthcare system in Austria. Another trend in the market is the growing demand for bioactive wound care products. These products contain substances such as growth factors, collagen, and extracellular matrix components that promote wound healing and tissue regeneration. The use of bioactive wound care products has shown promising results in the treatment of chronic wounds, such as diabetic foot ulcers and pressure ulcers. As the prevalence of chronic wounds continues to rise, the demand for bioactive wound care products is expected to increase.

Local special circumstances:
Austria has a well-developed healthcare system with a strong emphasis on patient care and quality. This has led to the availability of a wide range of wound care products in pharmacies across the country. Pharmacies in Austria play a crucial role in providing wound care products to patients, as they are easily accessible and offer personalized advice and guidance. The presence of knowledgeable pharmacists in pharmacies ensures that customers receive appropriate wound care products based on their specific needs.

Underlying macroeconomic factors:
The growing aging population in Austria is a significant macroeconomic factor driving the growth of the Wound Care (Pharmacies) market. With an aging population, the prevalence of chronic wounds, such as pressure ulcers and venous leg ulcers, is increasing. This has created a higher demand for wound care products in pharmacies. Additionally, the increasing healthcare expenditure in Austria has also contributed to the growth of the market, as it allows for the development and availability of advanced wound care products. In conclusion, the Wound Care (Pharmacies) market in Austria is witnessing growth due to customer preferences for advanced wound care products, the adoption of telemedicine, and the increasing demand for bioactive wound care products. The well-developed healthcare system and the presence of knowledgeable pharmacists in pharmacies contribute to the availability and accessibility of wound care products. The growing aging population and increasing healthcare expenditure are also driving factors for market growth.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)